Clinical trial
Evaluation of Pulmonary Fibrosis After Severe Interstitial Pneumonia Due to COVID-19 (SARS-CoV-2)
NCT06423560 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Pulmonary Fibrosis After Severe Interstitial Pneumonia Due to COVID-19 (SARS-CoV-2)
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2020
- Completion date
- May 16, 2024
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.